Effect of a Web-Based Management Guide on Risk Factors in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A JADE Randomized Clinical Trial

Chan, Juliana C. N. and Thewjitcharoen, Yotsapon and Nguyen, Thy Khue and Tan, Alexander and Chia, Yook Chin * and Hwu, Chii-Min and Jian, Du and Himathongkam, Thep and Wong, Kim-Leng and Choi, Yun Mi and Mirasol, Roberto and Mafauzy, Mohamed and Kong, Alice P S and Ma, Ronald C W and Chow, Elaine Y K and Ozaki, Risa and Lau, Vanessa and Fu, Amy W. C. and Hong, Eun-Gyoung and Yoon, Kun Ho and Tsang, Chiu Chi and Lau, Eric S. H. and Lim, Lee Ling and Luk, Andrea O Y (2022) Effect of a Web-Based Management Guide on Risk Factors in Patients with Type 2 Diabetes and Diabetic Kidney Disease: A JADE Randomized Clinical Trial. JAMA Network Open, 5 (3). ISSN 2574-3805

Full text not available from this repository. (Request a copy)
Official URL: https://jamanetwork.com/journals/jamanetworkopen/f...

Abstract

Importance: Diabetic kidney disease (DKD) and its comorbidities can be prevented by treating multiple targets. Technology-assisted team-based care with regular feedback and patient empowerment can improve the attainment of multiple targets and clinical outcomes in patients with type 2 diabetes, but the effects of this intervention on patients with DKD are unclear. Objective: To evaluate the effect of the Joint Asia Diabetes Evaluation (JADE) web portal, nurse reminders, and team-based care on multiple risk factors in patients with DKD. Design, setting, and participants: This 12-month multinational, open-label randomized clinical trial was conducted between June 27, 2014, and February 19, 2019, at 13 hospital-based diabetes centers in 8 countries or regions in Asia. All patients who participated had DKD. The intention-to-treat data analysis was performed from April 7 to June 30, 2020. Interventions: Patients were randomized in a 1:1:1 ratio at each site to usual care, empowered care, or team-based empowered care. All patients underwent a JADE web portal-guided structured assessment at baseline and month 12. Patients in the usual care and empowered care groups received a medical follow-up. Patients in the empowered care group also received a personalized JADE report and nurse telephone calls every 3 months. Patients in the team-based empowered care group received additional face-to-face reviews every 3 months from a physician-nurse team. Main outcomes and measures: The primary outcome was the proportion of patients who attained multiple treatment targets (defined as ≥3 of 5 targets: HbA1c level <7.0% [53 mmol/mol], blood pressure <130/80 mm Hg, low-density lipoprotein cholesterol level <1.8 mmol/L, triglyceride level <1.7 mmol/L, and/or persistent use of renin-angiotensin-aldosterone system inhibitors). Results: A total of 2393 patients (mean [SD] age, 67.7 [9.8] years; 1267 men [52.9%]) were randomized to the usual care group (n = 795), empowered care group (n = 802), and team-based empowered care group (n = 796). At baseline, 34.7% patients (n = 830) were on 3 treatment targets. On intention-to-treat analysis, the team-based empowered care group had the highest proportion of patients who had further increase in attainment of multiple treatment targets (within-group differences: usual care group, 3.9% [95% CI, 0.0%-7.8%]; empowered care group, 1.3% [95% CI, -2.8% to 5.4%]; team-based empowered care group, 9.1% [95% CI, 4.7%-13.5%]). The team-based empowered care group was more likely to attain multiple treatment targets than the usual care group (risk ratio [RR], 1.17; 95% CI, 1.00-1.37) and the empowered care group (RR, 1.25; 95% CI, 1.06-1.48) after adjustment for site. Compared with the group that did not attain multiple treatment targets, the group that attained multiple treatment targets reported a lower incidence of cardiovascular, kidney, and cancer events (8.4% [n = 51] vs 14.5% [n = 134]; P = .004). Analysis of the per-protocol population yielded similar results. Conclusions and relevance: This trial found that technology-assisted team-based care for 12 months improved the attainment of multiple treatment targets as well as empowerment in patients with DKD. Trial registration: ClinicalTrials.gov Identifier: NCT02176278.

Item Type: Article
Uncontrolled Keywords: diabetic kidney disease; technology-assisted-based care; empowered care; team-based empowered care;
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
Divisions: Others > Non Sunway Academics
Sunway University > School of Medical and Life Sciences [formerly School of Healthcare and Medical Sciences until 2020] > Department of Medical Sciences
Depositing User: Ms Yong Yee Chan
Related URLs:
Date Deposited: 08 Aug 2024 03:44
Last Modified: 08 Aug 2024 03:44
URI: http://eprints.sunway.edu.my/id/eprint/3034

Actions (login required)

View Item View Item